首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2075416

魚皮症市場：按類型、療法、給藥途徑、分銷管道和地區分類

Fish Skin Disease Market, By Type, By Treatment type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2026年04月29日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，2026年魚皮病市場規模為18.6億美元，預計2033年將達到36.2億美元。預計2026年至2033年，該市場將以10.0%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	18.6億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	10.00%	2033年市場規模預測：	36.2億美元

魚鱗病是一種以大面積皮膚持續增厚、乾燥、呈魚鱗狀的疾病。它是一個總稱，涵蓋一系列導致皮膚乾燥、發癢、鱗屑狀、粗糙和發紅的皮膚病。症狀輕重不一。雖然魚鱗病可能只影響皮膚，但某些類型也會影響內臟。目前已知的魚鱗病類型超過20種。有些類型是先天遺傳的，而有些則是在成年後發生的。治療可以減輕皮膚發紅、鱗屑增厚和搔癢。

市場動態：

魚鱗病患病率不斷上升、公眾意識提高、對安全有效的治療方法的需求不斷成長，以及市場參與者推出新的治療方法，預計這些因素將推動全球魚鱗病市場的成長。

例如，2023年4月，魚皮治療產品製造商Kerecis宣布推出“MariGen Shield”，這是一種用於治療慢性複雜傷口的解決方案，它將魚皮移植片與矽膠接觸層相結合。此矽膠接觸層有助於將圓形移植片固定指定，並在肉芽組織形成過程中保護傷口。

此外，2021年10月，Kerecis公司獲得了美國食品藥物管理局（FDA）頒發的「Omega3 SurgiBind」上市許可。「Omega3 SurgiBind」是一種可植入的魚皮移植片，用於整形和重組手術。本產品適用於需要進行軟組織修復或加固的整形或重組手術患者，以增強其脆弱的軟組織。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數，介紹了全球魚皮移植市場主要參與者的概況。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品等級改進、市場擴張和行銷策略做出明智的決策。
這份《全球魚類皮膚病市場》報告旨在為產業內的各類相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以利用全球魚類皮膚病市場分析中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 印度
- 中國
- 日本
- 澳洲
- ASEAN
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第10章競爭格局

GSK Plc.
AbbVie Inc.
Sonnet BioTherapeutics
Krystal Biotech
LEO Pharma
GALDERMA
GLENMARK PHARMACEUTICALS LTD.
Mayne Pharma Group Limited
Ortho Dermatologics
Cellegy Pharmaceuticals
Patagonia Pharmaceuticals, LLC
Crown Laboratories, Inc.

第11章

調查方法
關於本公司

簡介目錄

Product Code: CMI5696

Fish Skin Disease Market is estimated to be valued at USD 1.86 Bn in 2026 and is expected to reach USD 3.62 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1.86 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	10.00%	2033 Value Projection:	USD 3.62 Bn

Ichthyosis is a medical condition that causes widespread and persistent thick, dry, fish-scale skin. It is a group of skin disorders that lead to dry and itchy skin that appears scaly, rough, and red. The symptoms can range from mild to severe. Ichthyosis can affect only the skin, but some forms of the disease can affect internal organs as well. There are more than 20 different types of ichthyosis. Some types are inherited at birth, and others are acquired during adulthood. The treatment helps reduce the redness of the skin, thickness of the scales, and itching.

Market Dynamics:

The rise in burden of fish skin disease, the rise in awareness among people, the increase in demand for safe, effective treatments & therapies, and the introduction of novel treatments and therapies by market players are major factors expected to propel growth of the global fish skin disease market.

For instance, in April 2023, Kerecis, a manufacturer of fish skin-based therapeutic products announced the launch of the MariGen Shield, a solution that combines the company's fish-skin graft and a silicone contact layer to treat chronic and complex wounds. The silicone contact layer anchors the round graft in position and help safeguard granulating wound

Moreover, in October 2021, Kerecis received the U.S. Food and Drug Administration (FDA) marketing authorization for Omega3 SurgiBind. It is an implantable fish-skin graft intended for use in plastic and reconstructive surgery. It is indicated for strengthening weak soft tissue in patients who require soft tissue repair or reinforcement in plastic or reconstructive surgery.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global fish skin disease market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GSK Plc., AbbVie Inc., Sonnet BioTherapeutics, Krystal Biotech, LEO Pharma, GALDERMA, GLENMARK PHARMACEUTICALS LTD., Mayne Pharma Group Limited, Ortho Dermatologics, Cellegy Pharmaceuticals, Patagonia Pharmaceuticals, LLC, Crown Laboratories, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global fish skin disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fish skin disease market

Fish Skin Disease Market Detailed Segmentation:

By Type (Revenue, USD Bn, 2021 - 2033):
Ichthyosis vulgaris
X-linked recessive ichthyosis
Others (Autosomal recessive congenital ichthyosis, etc.)
By Treatment Type (Revenue, USD Bn, 2021 - 2033)
Corticosteroids
Emollients
Retinoids
Others (Keratolytics, etc.)
By Route of Administration (Revenue, USD Bn, 2021 - 2033)
Topical
Oral
Parenteral
By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles:
GSK Plc.
AbbVie Inc.
Sonnet BioTherapeutics
Krystal Biotech
LEO Pharma
GALDERMA
GLENMARK PHARMACEUTICALS LTD.
Mayne Pharma Group Limited
Ortho Dermatologics
Cellegy Pharmaceuticals
Patagonia Pharmaceuticals, LLC
Crown Laboratories, Inc.

Report Description
- Market Definition and Scope
Executive Summary
- Market Fish Skin Disease, By Type
- Market Fish Skin Disease, By Treatment Type
- Market Fish Skin Disease, By Route of Administration
- Market Fish Skin Disease, By Distribution Channel
- Market Fish Skin Disease, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rise in burden of fish skin disease across the globe
- Lack of awareness among people
- Increase in demand for safe and effective treatments/therapies
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER€(TM)s Analysis
Merger and Acquisition Scenario

4. Fish Skin Disease

Supply Side and Demand Side Analysis
Economic Impact

5. Fish Skin Disease Market, By Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Ichthyosis vulgaris
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)
X-linked recessive ichthyosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)
Others (Autosomal recessive congenital ichthyosis, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)

6. Fish Skin Disease Market, By Treatment Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)
Emollients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)
Retinoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)
Others (Keratolytics, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 €" 2033,(US$ Bn)

7. Fish Skin Disease Market, By Route of Administration, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

8. Fish Skin Disease Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

9. Fish Skin Disease Market, By Region, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 €"2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Bn)
  - India
  - China
  - Japan
  - Australia
  - ASEAN
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

GSK Plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sonnet BioTherapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Krystal Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LEO Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GALDERMA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GLENMARK PHARMACEUTICALS LTD.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mayne Pharma Group Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ortho Dermatologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cellegy Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Patagonia Pharmaceuticals, LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Crown Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views